// App-Quantinova.ai

: The association between KRAS mutational status, clinicopathological factors including the preoperative systemic inflammatory response and outcomes in TNM stage I-III colon cancer.

Researchers

Presenter

  • Allan Matthew Golder

Principal Investigators

  • Kathryn AF Pennel

  • David Mansouri

  • Paul G. Horgan

  • Campbell SD Roxburgh

  • Andrew V Biankin

  • Joanne Edwards

  • Donald C. McMillan

Medical Centers

  • Academic Unit of Surgery, University of Glasgow, Glasgow, United Kingdom

  • Academic Unit of Surgery, Glasgow, United Kingdom

  • University of Glasgow, Glasgow, United Kingdom

  • University of Glasgow, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved